What is the Eris Lifesciences Ltd share price today?

The share price of NSE:ERIS-EQ on 01 Oct 2026 (as of 15:03:29 IST) is ₹1183.9.

What is the NSE:ERIS-EQ 52 week high low price?

Over the past 52 weeks (as of 01 Oct 2026), the NSE:ERIS-EQ 52 week high low range shows a high of ₹1740 and a low of ₹1162.9.

What is the Eris Lifesciences Ltd market cap?

As on 01 Oct 2026, Eris Lifesciences Ltd market cap is ₹165113000000.

What is the shareholding pattern of Eris Lifesciences Ltd Stock?

The shareholding pattern of Eris Lifesciences Ltd, as of last reported-on 30 Jun 2026 is: Promoters: 54.14% Foreign Institutional Investors (FII): 5.76% Domestic Institutional Investors (DII): 1.83% Mutual Funds: 18.88% Retail & Others: 19.39% This demonstrates an outstanding distribution of ownership.

What are the PE and PB ratios of Eris Lifesciences Ltd?

The Price-to-Earnings (PE) ratio of Eris Lifesciences Ltd is 25.6422, and the Price-to-Book (PB) ratio is 4.624, as on 01 Oct 2026.

Eris Lifesciences Share Price

1219.60+4.60 (+0.38%)

-23.82% past 1 Year

Prices are delayed by 1 hour. Login or Sign Up for live updates.Prices are delayed by 1 hour. Login or Sign Up for live updates.

Login to analyze with FIA

1 Day

+0.38%

1 Week

+5.47%

1 Month

+2.95%

3 Month

-11.78%

6 Month

-12.01%

YTD

-19.00%

1 Year

-23.82%

5 Year

+49.59%

10 Year

NA

Max

+99.61%

1D

1W

1M

3M

6M

YTD

1Y

5Y

10Y

MAX

Prices are delayed by 1 hour. Login or Sign Up for live updates.Prices are delayed by 1 hour. Login or Sign Up for live updates.

Price Analysis

1 Day

1 Week

1 Month

3 Months

6 Months

1 Year

Low

1217.70

1150.60

1069.00

High

1236.80

1410.00

1530.00

1740.00

About

Eris Lifesciences Limited founded by Amit Bakshi and team in 2007 is one of the fastest growing companies within the chronic and acute categories of the Indian Branded Formulations market Read more

Pharmaceuticals & Drugs

Smallcap

Stock Analysis (SWOT)

StrengthsWeaknessesOpportunitiesThreats

1. Premium insight available after login

2. Sign in to view full SWOT analysis

3. Unlock strengths, weaknesses, opportunities & threats

QVT

Quality

0/100-

Valuation

0/100-

Technical

0/100-

Peer Stocks

1 week

1 month

1 year

Name

SUNPHARMANSE

DIVISLABNSE

TORNTPHARMNSE

LAURUSLABSNSE

ZYDUSLIFENSE

DRREDDYNSE

CIPLANSE

MANKINDNSE

AUROPHARMANSE

LUPINNSE

ERISNSE

LTP

1W Low

1W High

Market cap (₹)

1773.4-4.3 (-0.24%)

1722

1810.40

4,25,150Cr

10037.5+257.5 (2.63%)

9863

10067

2,66,265Cr

4738.5+125.1 (2.71%)

4553

4738.50

1,76,301Cr

2323.8-81.7 (-3.40%)

2252.40

2441.90

1,25,352Cr

1188.1-57.4 (-4.61%)

1182.40

1266.60

1,23,591Cr

1374+22 (1.63%)

1336.70

1376.70

1,14,351Cr

1402+23.1 (1.68%)

1364.60

1402

1,12,474Cr

2537.9+45.1 (1.81%)

2457.90

2540

1,02,315Cr

1705+23.6 (1.40%)

1656.20

1724.60

97,757Cr

2008.6-2.4 (-0.12%)

1988.90

2062.10

92,007Cr

1220+63.6 (5.50%)

1150.60

1220.10

16,335Cr

Eris Lifesciences Share Price

1219.60+4.60 (+0.38%)

-23.82% past 1 Year

Sign in to View

Open a free Demat account in minutes to start investing and screening .

Login Sign Up

Eris Lifesciences Share Price

1219.60+4.60 (+0.38%)

-23.82% past 1 Year

Financial overview

Compounded Sales Growth

10 years18%

5 years21%

3 years23%

Last year8%

Compounded Profit Growth

10 years17%

5 years12%

3 years17%

Last year73%

Stock Price CAGR

10 years-

5 years8%

3 years12%

1 year-24%

Return on Equity

10 years27%

5 years18%

3 years17%

Last year19%

CAGR%

Sales

Profits

Returns

ROE

10Y	5Y	3Y	TTM
18%	21%	23%	8%
17%	12%	17%	73%
-	8%	12%	-24%
27%	18%	17%	19%

Peer Comparison

Symbol

SUNPHARMA

DIVISLAB

TORNTPHARM

LAURUSLABS

ZYDUSLIFE

DRREDDY

CIPLA

MANKIND

AUROPHARMA

LUPIN

ERIS

Price	M.Cap (₹)	PE Ratio	EPS (₹)	EV/EBITDA	Annual PAT
1,793.2	₹426122 Cr	38.86	8.29	58.23	₹11479 Cr
9,985.5	₹266424 Cr	91.09	34.04	128.41	₹2568 Cr
4,701	₹179914 Cr	84.71	14.04	106.21	₹2163 Cr
2,294.8	₹124601 Cr	92.99	8.17	33.94	₹889 Cr
1,179	₹118703 Cr	28.4	9.27	62.23	₹5040 Cr
1,366.5	₹114599 Cr	40.93	11.08	59.16	₹4196 Cr
1,397.9	₹113112 Cr	39.04	10.86	52.6	₹3879 Cr
2,525.4	₹104631 Cr	46.66	17.23	76.26	₹1913 Cr
1,704.5	₹97878 Cr	26.36	19.57	96.84	₹3505 Cr
1,956	₹92145 Cr	17.7	25.26	150.99	₹5333 Cr
1,219.6	₹16891 Cr	23.87	13.25	71.57	₹620 Cr

Profit & Loss

Consolidated

Standalone

Quarterly

Yearly

₹

%

Name

Net Revenue

Other Income

Total Revenue

Total Expenditure

Operating Profit

Interest Expense

PBT

Net Profit

Sep 2026	Jun 2026	Mar 2026	Dec 2025	Sep 2025	Jun 2025	Mar 2025	Dec 2024	Sep 2024	Jun 2024	Mar 2024	Dec 2023	Sep 2023	Jun 2023	Mar 2023	Dec 2022	Sep 2022	Jun 2022	Mar 2022	Dec 2021	Sep 2021	Jun 2021	Mar 2021	Dec 2020	Sep 2020	Jun 2020	Mar 2020	Dec 2019	Sep 2019	Jun 2019	Mar 2019	Dec 2018	Sep 2018	Jun 2018	Mar 2018	Dec 2017	Sep 2017	Jun 2017	Mar 2017	Dec 2016	Sep 2016	Jun 2016
₹892 Cr	₹873 Cr	₹757 Cr	₹807 Cr	₹792 Cr	₹773 Cr	₹705 Cr	₹727 Cr	₹741 Cr	₹720 Cr	₹551 Cr	₹486 Cr	₹505 Cr	₹467 Cr	₹403 Cr	₹423 Cr	₹461 Cr	₹399 Cr	₹306 Cr	₹332 Cr	₹360 Cr	₹349 Cr	₹278 Cr	₹310 Cr	₹330 Cr	₹293 Cr	₹249 Cr	₹266 Cr	₹285 Cr	₹274 Cr	₹215 Cr	₹252 Cr	₹264 Cr	₹251 Cr	₹212 Cr	₹209 Cr	₹249 Cr	₹185 Cr	₹184 Cr	₹184 Cr	₹199 Cr	₹182 Cr
₹3 Cr	₹2 Cr	₹2 Cr	₹2 L	₹3 Cr	₹3 Cr	₹8 Cr	₹4 Cr	₹5 Cr	₹2 Cr	₹15 Cr	₹4 Cr	₹3 Cr	₹99 L	₹1 Cr	₹2 Cr	₹5 Cr	₹3 Cr	₹8 Cr	₹5 Cr	₹7 Cr	₹6 Cr	₹2 Cr	₹3 Cr	₹2 Cr	₹1 Cr	-₹1 Cr	₹8 Cr	₹5 Cr	₹3 Cr	₹12 Cr	₹10 Cr	₹6 Cr	₹4 Cr	₹7 Cr	₹6 Cr	₹6 Cr	₹7 Cr	₹5 Cr	₹6 Cr	₹9 Cr	₹5 Cr
₹896 Cr	₹876 Cr	₹759 Cr	₹807 Cr	₹795 Cr	₹776 Cr	₹713 Cr	₹732 Cr	₹746 Cr	₹721 Cr	₹566 Cr	₹491 Cr	₹509 Cr	₹468 Cr	₹404 Cr	₹425 Cr	₹466 Cr	₹401 Cr	₹314 Cr	₹337 Cr	₹367 Cr	₹355 Cr	₹280 Cr	₹313 Cr	₹332 Cr	₹295 Cr	₹248 Cr	₹275 Cr	₹290 Cr	₹277 Cr	₹227 Cr	₹263 Cr	₹270 Cr	₹254 Cr	₹219 Cr	₹215 Cr	₹256 Cr	₹192 Cr	₹189 Cr	₹190 Cr	₹208 Cr	₹188 Cr
₹656 Cr	₹649 Cr	₹553 Cr	₹596 Cr	₹573 Cr	₹567 Cr	₹530 Cr	₹558 Cr	₹557 Cr	₹545 Cr	₹456 Cr	₹357 Cr	₹366 Cr	₹338 Cr	₹319 Cr	₹316 Cr	₹338 Cr	₹293 Cr	₹227 Cr	₹227 Cr	₹235 Cr	₹237 Cr	₹195 Cr	₹214 Cr	₹216 Cr	₹200 Cr	₹186 Cr	₹202 Cr	₹187 Cr	₹181 Cr	₹164 Cr	₹168 Cr	₹172 Cr	₹169 Cr	₹150 Cr	₹135 Cr	₹157 Cr	₹118 Cr	₹141 Cr	₹118 Cr	₹130 Cr	₹114 Cr
₹313 Cr	₹299 Cr	₹276 Cr	₹282 Cr	₹291 Cr	₹279 Cr	₹260 Cr	₹255 Cr	₹269 Cr	₹252 Cr	₹164 Cr	₹180 Cr	₹185 Cr	₹171 Cr	₹120 Cr	₹139 Cr	₹157 Cr	₹132 Cr	₹105 Cr	₹127 Cr	₹147 Cr	₹132 Cr	₹97 Cr	₹110 Cr	₹127 Cr	₹105 Cr	₹76 Cr	₹85 Cr	₹115 Cr	₹107 Cr	₹74 Cr	₹104 Cr	₹107 Cr	₹92 Cr	₹79 Cr	₹87 Cr	₹104 Cr	₹78 Cr	₹54 Cr	₹78 Cr	₹83 Cr	₹79 Cr
₹46 Cr	₹47 Cr	₹46 Cr	₹49 Cr	₹50 Cr	₹49 Cr	₹54 Cr	₹57 Cr	₹59 Cr	₹60 Cr	₹33 Cr	₹18 Cr	₹16 Cr	₹17 Cr	₹9 Cr	₹3 Cr	₹7 Cr	₹7 Cr	₹1 Cr	₹1 Cr	₹1 Cr	₹78 L	₹54 L	₹40 L	₹45 L	₹41 L	₹35 L	₹39 L	₹51 L	₹91 L	₹4 Cr	₹5 Cr	₹6 Cr	₹7 Cr	₹8 Cr	₹3 Cr	₹2 L	₹2 L	₹19 L	₹3 L	₹79 L	₹3 L
₹157 Cr	₹180 Cr	₹161 Cr	₹145 Cr	₹172 Cr	₹160 Cr	₹129 Cr	₹116 Cr	₹129 Cr	₹116 Cr	₹77 Cr	₹116 Cr	₹126 Cr	₹112 Cr	₹76 Cr	₹107 Cr	₹121 Cr	₹101 Cr	₹85 Cr	₹109 Cr	₹131 Cr	₹117 Cr	₹85 Cr	₹99 Cr	₹116 Cr	₹95 Cr	₹61 Cr	₹72 Cr	₹103 Cr	₹95 Cr	₹58 Cr	₹89 Cr	₹92 Cr	₹78 Cr	₹62 Cr	₹77 Cr	₹99 Cr	₹74 Cr	₹48 Cr	₹72 Cr	₹78 Cr	₹73 Cr
₹188 Cr	₹144 Cr	₹280 Cr	₹109 Cr	₹134 Cr	₹124 Cr	₹102 Cr	₹87 Cr	₹96 Cr	₹90 Cr	₹80 Cr	₹101 Cr	₹122 Cr	₹94 Cr	₹61 Cr	₹100 Cr	₹119 Cr	₹93 Cr	₹80 Cr	₹101 Cr	₹118 Cr	₹107 Cr	₹68 Cr	₹90 Cr	₹108 Cr	₹89 Cr	₹56 Cr	₹63 Cr	₹93 Cr	₹84 Cr	₹54 Cr	₹80 Cr	₹86 Cr	₹72 Cr	₹56 Cr	₹75 Cr	₹93 Cr	₹71 Cr	₹47 Cr	₹68 Cr	₹69 Cr	₹63 Cr

Balance Sheet

Consolidated

Standalone

₹

%

Name

Equity And Liabilities

Share Capital

Share Warrants & Outstandings

Total Reserves

Reserve excluding Revaluation Reserve

Shareholder's Funds

Minority Interest

Secured Loans

Deferred Tax Assets / Liabilities

Other Long Term Liabilities

Long Term Provisions

Total Non-Current Liabilities

Current Liabilities

Trade Payables

Other Current Liabilities

Short Term Borrowings

Short Term Provisions

Total Current Liabilities

Total Liabilities

Contingent Liabilities

Total Debt

Assets

Gross Block

Less Accumulated Depreciation

Net Block

Capital Work in Progress

Non Current Investments

Long Term Investment

Long Term Loans & Advances

Other Non Current Assets

Total Non-Current Assets

Current Assets Loans & Advances

Currents Investments

Inventories

Sundry Debtors

Cash and Bank

Other Current Assets

Short Term Loans and Advances

Total Current Assets

Net Current Assets (Including Current Investments)

Total Assets

Book Value

Adjusted Book Value

Mar 2026	Mar 2025	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019	Mar 2018	Mar 2017	Mar 2016	Mar 2015	Mar 2014	Mar 2013	Mar 2012
—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
₹14 Cr	₹14 Cr	₹14 Cr	₹14 Cr	₹14 Cr	₹14 Cr	₹14 Cr	₹14 Cr	₹14 Cr	₹14 Cr	₹14 L	₹14 L	₹14 L	₹14 L	₹14 L
₹14 Cr	₹10 Cr	₹5 Cr	₹3 Cr	₹2 Cr	₹4 Cr	₹3 Cr	₹1 Cr	₹0	₹0	₹0	₹0	₹0	₹0	₹0
₹3875 Cr	₹2831 Cr	₹2568 Cr	₹2180 Cr	₹1893 Cr	₹1559 Cr	₹1280 Cr	₹1136 Cr	₹848 Cr	₹553 Cr	₹299 Cr	₹266 Cr	₹177 Cr	₹106 Cr	₹48 Cr
₹3875 Cr	₹2831 Cr	₹2568 Cr	₹2180 Cr	₹1893 Cr	₹1559 Cr	₹1280 Cr	₹1136 Cr	₹848 Cr	₹553 Cr	₹299 Cr	₹266 Cr	₹177 Cr	₹106 Cr	₹48 Cr
₹3903 Cr	₹2854 Cr	₹2586 Cr	₹2196 Cr	₹1908 Cr	₹1576 Cr	₹1296 Cr	₹1151 Cr	₹861 Cr	₹567 Cr	₹300 Cr	₹266 Cr	₹177 Cr	₹106 Cr	₹48 Cr
-₹7 Cr	₹417 Cr	₹636 Cr	₹25 Cr	-₹11 L	₹20,000	₹0	₹18 Cr	₹25 Cr	₹24 Cr	₹3 Cr	₹4 Cr	₹4 Cr	₹5 Cr	₹5 Cr
₹956 Cr	₹1738 Cr	₹655 Cr	₹644 Cr	₹45 Cr	₹0	₹0	₹29 L	₹274 Cr	₹49 L	₹0	₹50 L	₹0	₹56 L	₹3 Cr
₹62 Cr	₹229 Cr	₹227 Cr	-₹16 Cr	-₹197 Cr	-₹151 Cr	-₹120 Cr	-₹93 Cr	-₹48 Cr	-₹15 Cr	-₹6 Cr	-₹3 Cr	-₹21 L	-₹26 L	₹2 L
₹45 Cr	₹55 Cr	₹45 Cr	₹57 Cr	₹41 Cr	₹11 Cr	₹15 Cr	₹8 Cr	₹3 Cr	₹4 Cr	₹2 Cr	₹1 Cr	₹1 Cr	₹2 Cr	₹2 Cr
₹87 Cr	₹79 Cr	₹53 Cr	₹45 Cr	₹32 Cr	₹31 Cr	₹26 Cr	₹19 Cr	₹19 Cr	₹23 Cr	₹23 Cr	₹20 Cr	₹17 Cr	₹15 Cr	₹9 Cr
₹1150 Cr	₹2101 Cr	₹979 Cr	₹730 Cr	-₹79 Cr	-₹109 Cr	-₹80 Cr	-₹65 Cr	₹248 Cr	₹12 Cr	₹20 Cr	₹19 Cr	₹18 Cr	₹17 Cr	₹14 Cr
—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
₹330 Cr	₹332 Cr	₹219 Cr	₹125 Cr	₹118 Cr	₹103 Cr	₹100 Cr	₹84 Cr	₹91 Cr	₹39 Cr	₹25 Cr	₹37 Cr	₹37 Cr	₹22 Cr	₹18 Cr
₹1178 Cr	₹534 Cr	₹900 Cr	₹190 Cr	₹36 Cr	₹29 Cr	₹27 Cr	₹199 Cr	₹115 Cr	₹14 Cr	₹10 Cr	₹8 Cr	₹15 Cr	₹9 Cr	₹5 Cr
₹454 Cr	₹397 Cr	₹1311 Cr	₹55 Cr	₹1 L	₹1 L	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0
₹240 Cr	₹230 Cr	₹179 Cr	₹151 Cr	₹130 Cr	₹104 Cr	₹93 Cr	₹95 Cr	₹88 Cr	₹77 Cr	₹35 Cr	₹21 Cr	₹19 Cr	₹13 Cr	₹12 Cr
₹2201 Cr	₹1493 Cr	₹2609 Cr	₹521 Cr	₹283 Cr	₹235 Cr	₹220 Cr	₹377 Cr	₹294 Cr	₹129 Cr	₹69 Cr	₹65 Cr	₹71 Cr	₹44 Cr	₹35 Cr
₹7247 Cr	₹6866 Cr	₹6810 Cr	₹3472 Cr	₹2113 Cr	₹1703 Cr	₹1437 Cr	₹1481 Cr	₹1428 Cr	₹732 Cr	₹392 Cr	₹354 Cr	₹270 Cr	₹172 Cr	₹102 Cr
₹52 Cr	₹52 Cr	₹54 Cr	₹28 Cr	₹25 Cr	₹20 Cr	₹17 Cr	₹17 Cr	₹14 Cr	₹13 Cr	₹59 L	₹90 L	₹59 L	₹5 L	₹5 L
₹2310 Cr	₹2422 Cr	₹2735 Cr	₹830 Cr	₹45 Cr	₹1 L	₹0	₹176 Cr	₹377 Cr	₹65 L	₹50 L	₹1 Cr	₹53 L	₹3 Cr	₹5 Cr
—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
₹6162 Cr	₹6061 Cr	₹4773 Cr	₹2843 Cr	₹1092 Cr	₹1006 Cr	₹984 Cr	₹838 Cr	₹820 Cr	₹254 Cr	₹123 Cr	₹104 Cr	₹91 Cr	₹39 Cr	₹32 Cr
₹974 Cr	₹754 Cr	₹454 Cr	₹275 Cr	₹174 Cr	₹152 Cr	₹109 Cr	₹78 Cr	₹48 Cr	₹23 Cr	₹52 Cr	₹32 Cr	₹17 Cr	₹12 Cr	₹9 Cr
₹5188 Cr	₹5306 Cr	₹4319 Cr	₹2568 Cr	₹918 Cr	₹854 Cr	₹875 Cr	₹761 Cr	₹771 Cr	₹232 Cr	₹71 Cr	₹72 Cr	₹75 Cr	₹27 Cr	₹23 Cr
₹171 Cr	₹67 Cr	₹19 Cr	₹21 Cr	₹24 Cr	₹0	₹0	₹75 L	₹0	₹7 L	₹0	₹0	₹0	₹0	₹0
₹62 Cr	₹62 Cr	₹16 Cr	₹7 Cr	₹421 Cr	₹244 Cr	₹3 Cr	₹41 Cr	₹272 Cr	₹213 Cr	₹63 Cr	₹97 Cr	₹17 Cr	₹70,000	₹60,000
₹62 Cr	₹62 Cr	₹16 Cr	₹7 Cr	₹421 Cr	₹244 Cr	₹3 Cr	₹41 Cr	₹272 Cr	₹213 Cr	₹63 Cr	₹97 Cr	₹17 Cr	₹70,000	₹60,000
₹152 Cr	₹88 Cr	₹70 Cr	₹25 Cr	₹36 Cr	₹26 Cr	₹16 Cr	₹17 Cr	₹12 Cr	₹13 Cr	₹35 Cr	₹21 Cr	₹23 Cr	₹18 Cr	₹9 Cr
₹10 Cr	₹7 Cr	₹7 Cr	₹7 Cr	₹0	₹42 Cr	₹3 Cr	₹6 Cr	₹6 Cr	₹5 Cr	₹0	₹0	₹0	₹0	₹0
₹5583 Cr	₹5531 Cr	₹4431 Cr	₹2629 Cr	₹1402 Cr	₹1167 Cr	₹902 Cr	₹827 Cr	₹1061 Cr	₹463 Cr	₹169 Cr	₹190 Cr	₹115 Cr	₹45 Cr	₹33 Cr
—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
₹0	₹5 Cr	₹0	₹30 Cr	₹100 Cr	₹50 Cr	₹75 Cr	₹315 Cr	₹94 Cr	₹90 Cr	₹127 Cr	₹69 Cr	₹67 Cr	₹47 Cr	₹13 Cr
₹437 Cr	₹335 Cr	₹189 Cr	₹131 Cr	₹118 Cr	₹94 Cr	₹69 Cr	₹83 Cr	₹65 Cr	₹56 Cr	₹48 Cr	₹58 Cr	₹45 Cr	₹43 Cr	₹23 Cr
₹680 Cr	₹459 Cr	₹422 Cr	₹293 Cr	₹161 Cr	₹140 Cr	₹157 Cr	₹84 Cr	₹67 Cr	₹49 Cr	₹25 Cr	₹24 Cr	₹22 Cr	₹17 Cr	₹14 Cr
₹67 Cr	₹223 Cr	₹1401 Cr	₹58 Cr	₹52 Cr	₹38 Cr	₹67 Cr	₹8 Cr	₹11 Cr	₹2 Cr	₹10 Cr	₹6 Cr	₹7 Cr	₹5 Cr	₹9 Cr
₹44 Cr	₹26 Cr	₹32 Cr	₹22 Cr	₹24 Cr	₹36 Cr	₹55 Cr	₹58 Cr	₹44 Cr	₹4 Cr	₹2 Cr	₹2 Cr	₹3 Cr	₹89 L	₹40 L
₹435 Cr	₹287 Cr	₹335 Cr	₹308 Cr	₹256 Cr	₹176 Cr	₹111 Cr	₹107 Cr	₹86 Cr	₹68 Cr	₹10 Cr	₹5 Cr	₹11 Cr	₹14 Cr	₹9 Cr
₹1664 Cr	₹1334 Cr	₹2379 Cr	₹843 Cr	₹711 Cr	₹536 Cr	₹535 Cr	₹653 Cr	₹367 Cr	₹269 Cr	₹222 Cr	₹163 Cr	₹155 Cr	₹126 Cr	₹69 Cr
-₹537 Cr	-₹158 Cr	-₹230 Cr	₹321 Cr	₹428 Cr	₹300 Cr	₹315 Cr	₹276 Cr	₹73 Cr	₹140 Cr	₹153 Cr	₹98 Cr	₹84 Cr	₹83 Cr	₹34 Cr
₹7247 Cr	₹6866 Cr	₹6810 Cr	₹3472 Cr	₹2113 Cr	₹1703 Cr	₹1437 Cr	₹1481 Cr	₹1428 Cr	₹732 Cr	₹392 Cr	₹354 Cr	₹270 Cr	₹172 Cr	₹102 Cr
₹281	₹209	₹190	₹161	₹140	₹116	₹95	₹84	₹63	₹41	₹21,712	₹19,279	₹12,818	₹7,688	₹3,470
₹281	₹209	₹190	₹161	₹140	₹116	₹95	₹84	₹63	₹41	₹22	₹19	₹13	₹8	₹3

Cash Flow

Consolidated

Standalone

₹

%

Name

Profit Before Tax

Adjustment

Changes In working Capital

Cash Flow after changes in Working Capital

Cash Flow from Operating Activities

Cash Flow from Investing Activities

Cash Flow from Financing Activitie

Net Cash Inflow / Outflow

Opening Cash & Cash Equivalents

Cash & Cash Equivalent on Amalgamation / Take over / Merger

Closing Cash & Cash Equivalent

Mar 2026	Mar 2025	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019	Mar 2018	Mar 2017	Mar 2016	Mar 2015	Mar 2014	Mar 2013	Mar 2012
₹639 Cr	₹489 Cr	₹431 Cr	₹405 Cr	₹442 Cr	₹394 Cr	₹331 Cr	₹317 Cr	₹312 Cr	₹270 Cr	₹154 Cr	₹109 Cr	₹98 Cr	₹83 Cr	₹55 Cr
₹482 Cr	₹548 Cr	₹254 Cr	₹140 Cr	₹49 Cr	₹44 Cr	₹44 Cr	₹31 Cr	₹14 Cr	-₹65 L	₹20 Cr	₹12 Cr	₹69 L	₹7 Cr	₹3 Cr
-₹458 Cr	₹126 Cr	-₹99 Cr	-₹176 Cr	-₹30 Cr	₹5 Cr	-₹53 Cr	-₹53 Cr	-₹22 Cr	-₹16 Cr	-₹8 Cr	-₹8 Cr	₹21 Cr	-₹16 Cr	-₹11 Cr
₹662 Cr	₹1163 Cr	₹587 Cr	₹369 Cr	₹462 Cr	₹444 Cr	₹323 Cr	₹295 Cr	₹304 Cr	₹253 Cr	₹166 Cr	₹113 Cr	₹120 Cr	₹74 Cr	₹48 Cr
₹538 Cr	₹1065 Cr	₹486 Cr	₹292 Cr	₹378 Cr	₹375 Cr	₹271 Cr	₹223 Cr	₹235 Cr	₹200 Cr	₹131 Cr	₹90 Cr	₹90 Cr	₹38 Cr	₹30 Cr
-₹369 Cr	-₹80 Cr	-₹1855 Cr	-₹982 Cr	-₹320 Cr	-₹323 Cr	₹123 Cr	-₹5 Cr	-₹590 Cr	-₹184 Cr	-₹44 Cr	-₹92 Cr	-₹83 Cr	-₹36 Cr	-₹19 Cr
-₹314 Cr	-₹881 Cr	₹1380 Cr	₹688 Cr	-₹45 Cr	-₹82 Cr	-₹335 Cr	-₹221 Cr	₹363 Cr	-₹24 Cr	-₹84 Cr	₹46 L	-₹2 Cr	-₹3 Cr	-₹10 Cr
-₹145 Cr	₹104 Cr	₹11 Cr	-₹2 Cr	₹14 Cr	-₹30 Cr	₹60 Cr	-₹3 Cr	₹8 Cr	-₹8 Cr	₹4 Cr	-₹2 Cr	₹5 Cr	-₹77 L	₹100 L
₹200 Cr	₹94 Cr	₹56 Cr	₹51 Cr	₹37 Cr	₹67 Cr	₹8 Cr	₹11 Cr	₹2 Cr	₹9 Cr	₹5 Cr	₹7 Cr	₹2 Cr	₹3 Cr	₹2 Cr
₹0	₹2 Cr	₹27 Cr	₹7 Cr	₹0	₹0	₹0	₹0	₹52 L	₹1 Cr	₹0	₹0	₹0	₹0	₹0
₹55 Cr	₹200 Cr	₹94 Cr	₹56 Cr	₹51 Cr	₹37 Cr	₹67 Cr	₹8 Cr	₹11 Cr	₹2 Cr	₹9 Cr	₹5 Cr	₹7 Cr	₹2 Cr	₹3 Cr

Fundamental Ratios

Consolidated

Standalone

No results found

Eris Lifesciences Share Price

1219.60+4.60 (+0.38%)

-23.82% past 1 Year

02 Jan 25+9D

Bid/Ask

Price

Greeks

Stradle

Custom

CALLS

Qty/ots

PUTS

Sign in to View

Open a free Demat account in minutes to start investing and screening .

Login Sign Up

Eris Lifesciences Share Price

1219.60+4.60 (+0.38%)

-23.82% past 1 Year

Technical meters

Oscillators

Strong SellSellNeutralBuyStrong Buy

Bullish signals: 2

Bearish signals: 7 out of 9 oscillators

RSI

57.41Buy

STOCH %K

89.75Sell

MACD Level(12,26)

-9.20Sell

Ultimate Oscillator

44.50Sell

Aroon Oscillator

-56.00Sell

BOP

-0.81Sell

CCI

200.26Sell

Williams %R

-10.25Sell

Momentum

70.80Buy

Moving averages

Strong SellSellNeutralBuyStrong Buy

Bullish signals: 5

Bearish signals: 4 out of 9 moving averages

EMA 9

1180.14Buy

SMA 9

1174.61Buy

EMA 21

1178.06Buy

SMA 21

1155.53Buy

EMA 50

1223.52Sell

SMA 50

1230.93Sell

EMA 200

1351.36Sell

SMA 200

1344.78Sell

WMA 20

1163.45Buy

Pivot

Classic

Resistance 5

1372.03

Resistance 4

1330.13

Resistance 3

1288.23

Resistance 2

1246.33

Resistance 1

1230.67

Pivot

1204.43

Support 1

1188.77

Support 2

1162.53

Support 3

1120.63

Support 4

1078.73

Support 5

1036.83

High & lows

1 Day

1 Week

1 Month

3 Months

6 Months

Year to Date

1 Year

3 Years

5 Years

10 Years

All Time

Low

1217.70

1150.60

1069.00

809.15

551.30

321.00

High

1236.80

1410.00

1530.00

1563.00

1740.00

1910.00

Returns

+4.60

+63.20

+34.90

-162.80

-166.50

-286.00

-381.40

+346.60

+404.30

—

+608.60

Beta

—

Std. deviation %

—

Sign in to view

Open a free Demat account in minutes to start investing and screening .

Eris Lifesciences Share Price

1219.60+4.60 (+0.38%)

-23.82% past 1 Year

Shareholding summary

Promoters

54.74%

FII

5.74%

DII

2.21%

MF

17.98%

Others

19.33%

Promoters

FII

DII

MF

Others

Quarterly

Yearly

Shareholding Pattern

Quarterly

Yearly

Name

Promoters

FII

DII - Others

DII - MFs

Retail & Others

Sep 2026	Jun 2026	Mar 2026	Dec 2025	Sep 2025	Jun 2025
54.74%	54.14%	53.92%	54.85%	54.85%	54.83%
5.74%	5.76%	6.39%	6.85%	7.21%	8.39%
2.21%	1.83%	2.13%	2.05%	2.03%	1.40%
17.98%	18.88%	18.22%	18.26%	17.33%	16.78%
19.33%	19.39%	19.34%	17.99%	18.58%	18.60%

Bulk & block deals

Name

Motilal Oswal Financial Services Limited

Rakesh Shah

Infinity Partners

Emerald Investments Limited

Infinity Partners

Emerald Investments Limited

Franklin Templeton Mutual Fund

Rakesh Shah

Bhikhalal Chimanlal Shah

Deal Date	Action	Deal Value	Deal Price	Qty Traded	Deal Type	%Stake Traded	Exchange
03 Oct 2024	Purchase	280.70 Cr	₹1,350.18	20.79 L	Bulk	1.498501	NSE
03 Oct 2024	Sell	270 Cr	₹1,350	20 L	Bulk	1.44156	NSE
22 Aug 2024	Purchase	1,187.41 Cr	₹1,201	98.87 L	Bulk	7.126266	NSE
22 Aug 2024	Sell	1,187.41 Cr	₹1,201	98.87 L	Bulk	7.126266	NSE
22 Aug 2024	Purchase	1,187.41 Cr	₹1,201	98.87 L	Block	7.126266	NSE
22 Aug 2024	Sell	1,187.41 Cr	₹1,201	98.87 L	Block	7.126266	NSE
15 Jul 2024	Purchase	109.42 Cr	₹1,000.04	10.94 L	Bulk	0.788678	NSE
15 Jul 2024	Sell	200.02 Cr	₹1,000.12	20 L	Bulk	1.44156	NSE
31 Jan 2024	Sell	74.83 Cr	₹912.50	8.20 L	Bulk	0.59104	NSE
31 Jan 2024	Sell	116.88 Cr	₹913.09	12.80 L	Bulk	0.922598	BSE

Insider trading & SAST

Client name

Emerald Investments Ltd

Infinity Partners

Lilac Investments Ltd

Hdfc Mutual Fund

Uti Mutual Fund & Pacs

Uti Mutual Fund

Hdfc Mutual Fund

Reported on	Client category	Action	%Stake traded	Holding % post deal	Deal price	Qty traded	Deal period	Deal mode	Post transaction holding	Insider/SAST	Regulation type	Security type
29 Aug 2024	Other	Disposal	7.27	—	—	98.87 L	22 Aug 2024	Market	—	SAST	29(2)	—
29 Aug 2024	Other	Disposal	7.27	—	—	98.87 L	22 Aug 2024	Off Market	—	SAST	29(2)	—
29 Aug 2024	Other	Acquisition	7.27	7.27	—	98.87 L	22 Aug 2024	Market / Inter-se Transfer	98,86,882	SAST	29(1)	—
29 Aug 2024	Other	Acquisition	7.27	7.27	—	98.87 L	22 Aug 2024	Off Market	98,86,882	SAST	29(1)	—
16 May 2024	Other	Acquisition	2	7.13	—	27.21 L	14 May 2024	Market	96,96,364	SAST	29(2)	—
08 May 2024	Other	Disposal	0.02	4.98	—	28 K	03 May 2024	Market	67,79,886	SAST	29(2)	—
13 Feb 2024	Other	Acquisition	0.05	5.02	—	74.88 K	07 Feb 2024	Market	68,32,640	SAST	29(1)	—
09 Feb 2024	Other	Acquisition	0.05	5.02	—	75 K	07 Feb 2024	Market	68,32,640	SAST	29(1)	—
04 Jan 2024	Other	Disposal	0.1	4.98	—	1.40 L	19 Dec 2023	Market	67,86,730	SAST	29(2)	—
04 Jan 2024	Other	Acquisition	0.15	5.13	—	2 L	15 Dec 2023	Market	69,75,299	SAST	29(1)	—

Eris Lifesciences Share Price

1219.60+4.60 (+0.38%)

-23.82% past 1 Year

Eris Lifesciences Limited founded by Amit Bakshi and team in 2007 is one of the fastest growing companies within the chronic and acute categories of the Indian Branded Formulations market

Corporate Actions

Date

Type

Details

2026-05-29

Dividend

7.21

2025-02-13

Dividend

7.35

2020-08-13

Dividend

5.5

2020-03-19

Dividend

2.87

Company details

Registered office

Shivarth Ambit, Plot No. 142/2 Ramdas Road, Off S B R Near Swati Bungalows, Bodakdev Ahmedabad Gujarat PIN: 380054 Tel No: 079 30451000 / 1001 Fax No: 079 30179404 Email: [email protected] Internet: www.eris.co.in

Registrars

C 101, 247 Park, LBS Marg, Vikhroli (W), Mumbai(Old Address:) C-13 Pannalal Silk Compound, L B S Marg, Bhandup Mumbai Maharashtra C 101, 247 Park LBS Marg Vikhroli (West) PIN: Tel No: +91 810 811 8484 Fax No: 91-022-49186060 Email: [email protected] Internet: https://in.mpms.mufg.com/

Management

Milind Talegaonkar, Company Secretary & Compliance Officer

Amit Indubhushan Bakshi, Chairman & Managing Director

Inderjeet Singh Negi, Whole Time Director

Kaushal Shah, Whole Time Director

Sujesh Vasudevan, Non Executive Independent Director

Kalpana Unadkat, Non Executive Independent Director

Prashant Gupta, Non Executive Independent Director

Vineet Varma, Non Executive Independent Director

Details

Eris Lifesciences Share Price

Price Analysis

Share Price Live Stats

Share Market Cap & Key Ratios Overview

About

Stock Analysis (SWOT)

QVT

Peer Stocks

Eris Lifesciences Share Price

Eris Lifesciences Share Price

Financial overview

Compounded Sales Growth

Compounded Profit Growth

Stock Price CAGR

Return on Equity

Peer Comparison

Profit & Loss

Balance Sheet

Cash Flow

Fundamental Ratios

Eris Lifesciences Share Price

Eris Lifesciences Share Price

Oscillators

Moving averages

Eris Lifesciences Share Price

Shareholding summary

Shareholding Pattern

Bulk & block deals

Insider trading & SAST

Eris Lifesciences Share Price

Corporate Actions

Company details

Eris Lifesciences Share Price

Corporate filings & documents

Announcements

Annual reports

Concalls & investor presentations

Eris Lifesciences Share Price

News

Eris Lifesciences Reports Rs 52.91 Crore Block Trade At Rs 1171

Macquarie Maintains Outperform Rating On Eris Lifesciences

Eris Reports Strong Second Quarter Revenue Growth Year On Year

Eris reports higher second quarter EBITDA despite margin contraction

Eris Lifesciences Reports Strong Second Quarter Consolidated Profit Growth

Eris Lifesciences COO Krishna Kumar Vaidyanathan steps down

Eris Lifesciences to meet analysts and investors on August 27

Eris Lifesciences Q1 EBITDA margin below long-term FY27 guidance range

Eris Lifesciences Q1 revenue grows 13 percent, below FY27 guidance pace

Eris Lifesciences Q1 FY earnings show EBITDA growth but margin compression

Eris Lifesciences reports strong Q1 revenue growth on year-over-year basis

Eris Lifesciences Q1 consolidated net profit rises 16.7 percent year-on-year

Eris Lifesciences sets ambitious FY27 revenue growth and margin targets

Eris Lifesciences - Quaterly Results

Eris Lifescience guides FY27 revenue growth at 18 to 20 percent

Eris Lifesciences issues FY27 revenue growth guidance of 18-20 percent

Eris Lifesciences reports Profit after tax of Rs -8.60 Crores, in the March 2026 quarter

Eris Lifesciences Q4 FY26 EBITDA grows with marginal improvement in margins

Eris Lifesciences posts year-on-year revenue growth in Q4 earnings update

Eris Lifesciences Q4 consolidated net profit surges sharply year-on-year

Eris Lifesciences Ltd Share Price Today

Eris Lifesciences Quick Links

Other Stocks

Calculators

Brokerage Calculator

Stock Average Calculator

MTF Calculator

Margin Calculator

Span Margin Calculator